BACKGROUND: The aim of this study was to compare the clinical performance of 2 sensitive cTnI assays with 10 % CV imprecision below the 99th percentile upper reference limit. METHODS: We measured cardiac troponin and N-terminal pro–brain natriuretic peptide (NT-proBNP) concentrations in a random sample of the Global Use of Strategies To Open Occluded Coronary Arteries (GUSTO) IV cohort (n 1251). Outcome data of 1-year mortality and the composite endpoint DMI [death and/or myocardial infarction (MI) within 30 days] were available in all patients. The 99th percentile of a healthy populationwas estimated from the Sweden Women and Men and Ischemic Heart Disease (SWISCH) cohort (n 442). We measured cardiac troponin I (cTnI) using the Access Ac...
clinical performance of the cardiac troponin I (cTnI) assay from Beckman-Coulter Diagnostics. This a...
Background: Cardiac troponins currently represent the preferred biomarkers for the detection of myoc...
Cardiac specific troponin I and T (cTnI, cTnT) are well established biomarkers in patients presentin...
OBJECTIVES: The aim of this study is to determine the imprecision profile, 99th percentile and diag...
BACKGROUND: Cardiac troponin assays have been clas-sified according to whether they measure the 99th...
ObjectivesThis study sought to evaluate the analytical and clinical performance of the novel hyperse...
Background: Cardiac troponins (cTns) are the ‘gold standard’ biomarker for the diagnosis and prognos...
BACKGROUND: A cardiac troponin concentration above the 99th percentile limit of a reference populat...
Background: Cardiac troponins currently represent the preferred biomarkers for the detection of myoc...
BACKGROUND: The aim of this study was to validate the clinical performance of the Beckman Access hig...
Background: High-sensitivity cardiac troponin I (hs-cTnI) assays have been developed that quantify l...
Background: High-sensitivity cardiac troponin I (hs-cTnI) assays have been developed that quantify l...
Background: Until now, high-sensitivity cardiac troponin (hs-cTn) assays were mainly developed for l...
Background: Efficient rule-out of acute myocardial infarction (MI) facilitates early disposition of ...
clinical performance of the cardiac troponin I (cTnI) assay from Beckman-Coulter Diagnostics. This a...
Background: Cardiac troponins currently represent the preferred biomarkers for the detection of myoc...
Cardiac specific troponin I and T (cTnI, cTnT) are well established biomarkers in patients presentin...
OBJECTIVES: The aim of this study is to determine the imprecision profile, 99th percentile and diag...
BACKGROUND: Cardiac troponin assays have been clas-sified according to whether they measure the 99th...
ObjectivesThis study sought to evaluate the analytical and clinical performance of the novel hyperse...
Background: Cardiac troponins (cTns) are the ‘gold standard’ biomarker for the diagnosis and prognos...
BACKGROUND: A cardiac troponin concentration above the 99th percentile limit of a reference populat...
Background: Cardiac troponins currently represent the preferred biomarkers for the detection of myoc...
BACKGROUND: The aim of this study was to validate the clinical performance of the Beckman Access hig...
Background: High-sensitivity cardiac troponin I (hs-cTnI) assays have been developed that quantify l...
Background: High-sensitivity cardiac troponin I (hs-cTnI) assays have been developed that quantify l...
Background: Until now, high-sensitivity cardiac troponin (hs-cTn) assays were mainly developed for l...
Background: Efficient rule-out of acute myocardial infarction (MI) facilitates early disposition of ...
clinical performance of the cardiac troponin I (cTnI) assay from Beckman-Coulter Diagnostics. This a...
Background: Cardiac troponins currently represent the preferred biomarkers for the detection of myoc...
Cardiac specific troponin I and T (cTnI, cTnT) are well established biomarkers in patients presentin...
Add to ORKG